Menu Close

GOOD HEALTH FOR ALL

INNOVATION AS CORE SPIRIT

Our name is inspired from the blazing glow around the sun that shines through during a total solar eclipse spreading hope, growth and prosperity.

We are CORONA Remedies Pvt. Ltd. Our journey started in 2004, with a commitment to creating a better quality of health for all by being at the forefront of research, manufacturing and marketing of high quality products.

Our reach all over India, faster acceptance among the medical fraternity and our path breaking efforts proudly positioned us as one of the India’s youngest company to be into top 40 pharmaceutical companies.

This prodigious success is a result of our continuous commitment to innovative product development and manufacturing capabilities at world class PIC compliant capability that adhere to global quality standards.

We are among the leaders in Women Healthcare, and have a strong presence in various therapies such as Anti-hypertensive, Diabetes, Neuropathy, Hormones, Pain management, Dermatology, Bone Health, Anti-ulcerant & Nutritional supplements.

Our Vision

To achieve good health for every individual, society and the nation as a whole by becoming one of the top pharmaceutical companies in the world

Our Mission

To be an ethical, transparent, spirited, and vibrant organization with a progressive outlook, is to make available a range of innovative, value-added and evidence-based products

Corona Strength in Numbers

0 +

Brands

0 +

Employees

0

C&F SETUPS

0 +

Distributors

0 +

Clinicians Coverage

0 +

Pharmacies & Hospitals Reach

CORONA Journey

2004
Foundation Year with the launch of 1st Division: PIONEER
2005
Launched 2nd Division: XEMX
2006
Laid foundation for our 1st manufacturing plant at Solan, Himachal Pradesh
2007
Geographical expansion in East & South India
2008
Launched speciality Women’s Healthcare Division - Aarush

Started global operations with an entry into Kenya market
2009
Expansion of Solan plant with dedicated hormonal manufacturing unit
2010
We have entered in Top 100 pharmaceutical companies
2011
With a mission to serve every Indian Hypertensive patients, launched CORTEL - An affordable Telmisartan
2012
Expansion of international business in Mauritius, Nigeria, Zambia and Srilanka

Launched speciality CVD Division - Wellness
2013
1st Micronized Argihope Tablet - Our commitment towards Women’s Health with an iconic brand innovation

We secured 50th rank in Indian Pharmaceutical Market
2015
Ventured in to the South East Asian Countries such as Philippines, Myanmar, Cambodia, Vietnam and Thailand
2016
Footprints into West Africa countries as a contract manufacturer to Strides Arco lab
2017
Brand acquisitions of Vitneurin, Stelbid, Dilo DX and Dilo BM from GSK and consolidated our position in VMN, Respiratory and Gastroenterology segments

CORONA’s flagship brand B-29 has been recognized with “Asia’s Most Admired Brand Award”

Launched 2 Speciality Divisions:
AURA - 2nd CVD Division
SOLIS - 2nd Women's Healthcare Division
2018
Continued the inorganic growth trajectory with an acquisition of Obimet and Thyrocab range from Abbott and strengthened ourselves in Diabetes and Thyroid management
2019
Initiated the process of registering our own brands in West Africa and other CIS countries
2020
Made a Strategic alliance with La-Chandra Pharmalab strengthens gynecological & hormonal product range
2021
Commencement of EU GMP Compliant Plant
2021
Made a Strategic co-marketing partnership with Albert David for Human Placental Extract
2022
Field force expansion by 20% to strengthen ourselves in Gynaecology and CVD segment

Launched 2 Speciality Divisions:
RADIANCE - 3rd CVD Division
SOLARIS - 3rd Women's Healthcare Division

Milestones & Recognitions

Our Leading Brands